detalle del documento
IDENTIFICACIÓN

doi:10.1186/s12894-023-01299-2...

Autor
Tang, Wen Xie, Zhifei Liu, Mingwen Zhao, ZeJu Wu, Tao
Langue
en
Editor

BioMed Central

Categoría

Urology

Año

2023

fecha de cotización

2/8/2023

Palabras clave
uroseptic shock pregnancy iabp crrt va-ecmo treatment rate pregnancy
Métrico

Resumen

Background Uroseptic shock secondary to ureteral calculi during pregnancy is rare.

It is characterized by rapid onset, rapid progression, aggressive disease, limited treatment, poor prognosis, and a mortality rate higher than 20% with improper or delayed management.

A clear diagnosis is made based on typical clinical symptoms and abdominal ultrasound, often requiring combined multidisciplinary treatment and the simultaneous release of the obstruction.

The high mortality rate is mainly related to inappropriate early treatment of stones and infections or failure to intervene in a timely manner.

Case presentation A 21-year-old first-time pregnant patient with uroseptic shock was admitted to our intensive care unit.

The patient was successfully treated at our hospital with multidisciplinary cooperation, high-dose vasoactive drugs, IABP, CRRT, VA-ECMO, and termination of pregnancy.

Conclusions Timely relief of obstructions, termination of pregnancy, and the provision of IABP, CRRT, and VA-ECMO when necessary in critically ill patients with uroseptic shock during pregnancy can improve the success rate of resuscitation.

Tang, Wen,Xie, Zhifei,Liu, Mingwen,Zhao, ZeJu,Wu, Tao, 2023, Analysis of uroseptic shock after ureteroscopy for ureteral calculi during pregnancy: a case report, BioMed Central

Documento

Abrir

Compartir

Fuente

Artículos recomendados por ES/IODE IA

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder